What researchers published on Vesedaganat
4150 papers, newest first.
Showing 40 of 4150
Clinicopathologic significance of PD-L1 expression in clear cell renal cell carcinoma.Medicine
Esetismertetés[Diagnostic dilemma and surgical management of recurrent small bowel bleeding detected by SPECT/CT].Khirurgiia
Long-read RNA sequencing reveals full-length HERV transcripts and novel ERVE-4 isoforms with potential immunotherapeutic relevance in clear cell renal cell carcinoma.Frontiers in molecular biosciences
Insights into clear cell renal cell carcinoma microenvironment: LOXL2 expression and topographical layout of CD3+ T lymphocytes.Folia histochemica et cytobiologica
Endothelial activation and stress index as a prognostic marker in metastatic renal cell carcinoma.Frontiers in medicine
Multiomics tissue segmentation via spatially-informed nested biclustering methods.Biometrics
The Predictive Value of Endoglin for Fatal Outcomes in Renal Cell Carcinoma.Journal of kidney cancer and VHL
Xylarimides A and B, Unusual 21 Membered Cyclic Depsipeptides Featuring a 3-Furan-2-Hydroxypropionic Acid Unit, Target ATG7 to Induce Lethal Autophagy in Renal Cancer Cells.Organic letters
Enhancing the Specificity of the CAIX-Targeted Radionuclide Probe via the Optimization Cyclic Peptide Cyclization Linker.Journal of medicinal chemistry
Adjuvant Pembrolizumab in Patients with Clear Cell Renal Cell Carcinoma: From Eligibility to Individual Treatment Decision.European urology oncology
EsetismertetésEn Bloc Sutureless Patch Repair of the Inferior Vena Cava and Right Hepatic Vein in a Patient with Invasive Renal Cell Carcinoma: A Case Report.Surgical case reports
EsetismertetésCase Report: Metachronous colon metastasis of clear-cell renal cell carcinoma seven years after radical nephrectomy.Frontiers in oncology
ÁttekintésProstate Metastasis in Renal Cell Carcinoma: Rare Occurrence and Clinical Insights.Journal of the College of Physicians and Surgeons--Pakistan : JCPSP
Immune microenvironment biomarkers linked to ferroptosis in clear cell renal cell carcinoma.Frontiers in genetics
Intense 18F-FDG Activity in the Urachal Calculus in a Patient With a History of Renal Cell Carcinoma.Clinical nuclear medicine
Analysis of prognostic factors for survival after curative resections of clear-cell renal cell carcinoma based on Bayesian networks.Frontiers in oncology
Red Laser-Assisted Zero-Ischaemia <em>versus</em> Warm-Ischaemia Laparoscopic Partial Nephrectomy for cT1a Renal Masses.Journal of the College of Physicians and Surgeons--Pakistan : JCPSP
Label-Free Morphometric Profiling of Renal Cell Carcinoma Using Digital Holographic Microscopy and Machine Learning.Journal of biophotonics
Szisztematikus áttekintésC-reactive protein-albumin-lymphocyte index and survival outcomes in renal cell carcinoma: a systematic review and meta-analysis.Frontiers in oncology
Metabolomic profiling of renal cell carcinoma to identify prognostic markers of metastasis.PloS one
Integrated single-cell and bulk transcriptomic analyses reveal ferro-aging-related molecular characteristics and immunological heterogeneity in renal cell carcinoma.PloS one
[Features and prognostic significance of nuclear grade heterogeneity in multiple primary renal cell carcinoma].Zhonghua zhong liu za zhi [Chinese journal of oncology]
ÁttekintésBiomarker-led advances in renal cell carcinoma diagnosis, progression monitoring and therapeutic decision-making.Expert review of molecular diagnostics
ZNF460-SNRPB-RDM1 splicing axis promotes clear cell renal cell carcinoma progression through regulation of DNA damage repair.Apoptosis : an international journal on programmed cell death
EsetismertetésSynchronous ipsilateral clear cell renal cell carcinoma and upper tract urothelial carcinoma complicated by ureteral stone: a case report.Journal of surgical case reports
Midkine identifies a Treg-enriched immune-evasive phenotype associated with poor outcomes in clear cell renal cell carcinoma.Journal for immunotherapy of cancer
Reframing surgical strategy for renal cell carcinoma with inferior vena cava tumor thrombus: From classification to integrated multimodal care.Current urology
YAP delactylation enhances therapy resistance in renal cell carcinoma.Cell death & disease
Geometry based gene-expression signatures detect cancer treatment responders in clinical trials.BMC cancer
EsetismertetésAnesthetic management of right radical nephrectomy and inferior vena cava thrombectomy for giant renal cell carcinoma: a case report.International journal of surgery case reports
Vizsgálati eredménySpatial transcriptomics tumor microenvironment determinants of tyrosine kinase inhibitor response in renal cell carcinoma: results from a phase 2 clinical trial.Signal transduction and targeted therapy
ÁttekintésOptimizing treatment sequencing in renal cell carcinoma in an evolving therapeutic landscape.Clinical advances in hematology & oncology : H&O
TP53 shapes tumour-specific immune phenotypes across breast, colorectal and kidney human cancers.Journal of molecular medicine (Berlin, Germany)
ÁttekintésRadical and Partial Nephrectomy: Complications.The Urologic clinics of North America
Advances in systemic therapy for renal cell carcinoma from treatment intensification to individualized treatment selection.Chinese journal of cancer research = Chung-kuo yen cheng yen chiu
FGD5-AS1/miR-106b-5p/FDX1 axis governs cuproptosis to affect clear cell renal cell carcinoma progression via metabolic-immune crosstalk.Medical oncology (Northwood, London, England)
The YTHDF1/CAV1 axis regulates clear cell renal cell carcinoma progression through ferroptosis and apoptosis.Biology direct
Lenvatinib dose intensity and tumor response in renal cell carcinoma: considering tumor burden and nephrectomy timing.Japanese journal of clinical oncology
ÁttekintésOptimized pharmacotherapeutic management of immune checkpoint inhibitor treatment in metastatic clear-cell renal cell carcinoma.Expert opinion on pharmacotherapy
Lenvatinib dose intensity and tumor response in renal cell carcinoma: considering tumor burden and nephrectomy timing.Japanese journal of clinical oncology